Updated: 6/12/2019


Review Topic
Newborn 2 months 4 months 6 months 12 months 15 months 2 years 4-6 years 11-12 years
Hep B #1 Hep B #2   Hep B #3          
  DTaP DTaP DTaP   DTaP   DTaP  
  PPV PPV PPV          
  HiB HiB HiB HiB        
  Polio #1 Polio #2 Polio #3       Polio #4  
  Rota Rota            
        MMR     MMR  
  • Immunization allows for individuals to be protected against disease
  • Immunity can be conferred in two ways including
    • active immunity that is maintained by the immune system
    • passive immunity that is given transiently from outside
  • Vaccinations are a major source of conferring immunity outside normal infection and include
    • viral vaccines divided into
      • killed vaccines
      • live attenuated vaccines 
    • bacterial vaccines
  • Often vaccinations require an adjuvent that
    • enhances the immune reaction against the vaccine provided
    • increases the development of memory to non inflammatory antigens
    • can be of several types including
      • aluminum potassium sulfate
      • muramyl dipeptide
      • LPS/polyribonucleotides
  • Though vaccines are generally safe, contraindications to their use include
    • people with egg allergies who should avoid 
      • yellow fever vaccine and other vaccines made in eggs
    • pregnant women who should avoid 
      • rubella vaccines
    • immunocompromised individuals who should avoid
      • all live vaccines
Active vs Passive Immunity
  • Immunity can be either active or passive with several notable differences
Differences Between Active and Passive Immunity
Feature Passive
Acquisition method
  • Receiving preformed antibodies
  • Exposure to infection or to foreign antigens
  • Maternal IgG crossing placenta
  • Babies getting IgA in breast milk
  • Administration of antitoxin
  • Infection with the specific pathogen
  • Administration of a vaccine
  • Immediate upon administration
  • Slow to allow for development of full immune response      
  • Very short with a half life between two weeks and four weeks
  • Long or even lifetime
  • Due to generation of memory
Viral Vaccines
  • Viral vaccines can either be live attenuated or killed with several notable differences
Differences Between Live and Killed Vaccines
Feature Live
Production method
  • Design a nonpathogenic version of a virus that can still grow transiently in the host
  • Inactive pathogen or pathogen antigens by treatment with heat or chemicals
  • Induce both cellular and humoral responses
  • induces lifelong immunity (usually)
  • Safer than live vaccines because they cannot revert to pathogenic state
  • Cannot give to immunocompromised patients
  • Small chance of reverting to pathogenic state
  • Weaker response (usually only humoral)
  • May require booster shots      
  • Everything else
  • MMR
  • VZV
  • Polio (Sabin)
  • Etc
  • Rest In Peace Always 
  • Rabies
  • Influenza
  • Polio (Salk)
  • Hepatitis A
Bacterial Vaccination
  • Bacterial vaccination involves administration of characteristic protein which can be
    • inactivated toxin produced by pathogen called a toxoid
    • coat protein that surrounds the pathogen called a capsule
    • other important proteins that are conserved by the pathogen 
  • Select examples of vaccines against pathogenic bacteria include
    • DTaP that is composed of
      • C. diptheriae toxoid
      • C. tetani toxoid
      • B. pertussis toxoid
    • H. influenzae capsular type B
    • S. pneumoniae that comes in two forms including
      • a pediatric version with
        • 7 capsule types
        • think: a 7 year old gets PCV
      • an adult version with
        • 23 capsular types
    • N. meningitidis with 4 capsular proteins


Please rate topic.

Average 4.9 of 11 Ratings

Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine

The complexity of this topic is appropriate for?
How important is this topic for board examinations?
How important is this topic for clinical practice?
Questions (1)
Lab Values
Blood, Plasma, Serum Reference Range
ALT 8-20 U/L
Amylase, serum 25-125 U/L
AST 8-20 U/L
Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL
Calcium, serum (Ca2+) 8.4-10.2 mg/dL
Cholesterol, serum Rec: < 200 mg/dL
Cortisol, serum 0800 h: 5-23 μg/dL //1600 h:
3-15 μg/dL
2000 h: ≤ 50% of 0800 h
Creatine kinase, serum Male: 25-90 U/L
Female: 10-70 U/L
Creatinine, serum 0.6-1.2 mg/dL
Electrolytes, serum  
Sodium (Na+) 136-145 mEq/L
Chloride (Cl-) 95-105 mEq/L
Potassium (K+) 3.5-5.0 mEq/L
Bicarbonate (HCO3-) 22-28 mEq/L
Magnesium (Mg2+) 1.5-2.0 mEq/L
Estriol, total, serum (in pregnancy)  
24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL
28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL
Ferritin, serum Male: 15-200 ng/mL
Female: 12-150 ng/mL
Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL
Female: premenopause: 4-30 mIU/mL
midcycle peak: 10-90 mIU/mL
postmenopause: 40-250
pH 7.35-7.45
PCO2 33-45 mmHg
PO2 75-105 mmHg
Glucose, serum Fasting: 70-110 mg/dL
2-h postprandial:<120 mg/dL
Growth hormone - arginine stimulation Fasting: <5 ng/mL
Provocative stimuli: > 7ng/mL
Immunoglobulins, serum  
IgA 76-390 mg/dL
IgE 0-380 IU/mL
IgG 650-1500 mg/dL
IgM 40-345 mg/dL
Iron 50-170 μg/dL
Lactate dehydrogenase, serum 45-90 U/L
Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL
Female: follicular phase: 5-30 mIU/mL
midcycle: 75-150 mIU/mL
postmenopause 30-200 mIU/mL
Osmolality, serum 275-295 mOsmol/kd H2O
Parathyroid hormone, serume, N-terminal 230-630 pg/mL
Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L
Phosphorus (inorganic), serum 3.0-4.5 mg/dL
Prolactin, serum (hPRL) < 20 ng/mL
Proteins, serum  
Total (recumbent) 6.0-7.8 g/dL
Albumin 3.5-5.5 g/dL
Globulin 2.3-3.5 g/dL
Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL
Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h
Thyroxine (T4), serum 5-12 μg/dL
Triglycerides, serum 35-160 mg/dL
Triiodothyronine (T3), serum (RIA) 115-190 ng/dL
Triiodothyronine (T3) resin uptake 25%-35%
Urea nitrogen, serum 7-18 mg/dL
Uric acid, serum 3.0-8.2 mg/dL
Hematologic Reference Range
Bleeding time 2-7 minutes
Erythrocyte count Male: 4.3-5.9 million/mm3
Female: 3.5-5.5 million mm3
Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/h
Female: 0-20 mm/h
Hematocrit Male: 41%-53%
Female: 36%-46%
Hemoglobin A1c ≤ 6 %
Hemoglobin, blood Male: 13.5-17.5 g/dL
Female: 12.0-16.0 g/dL
Hemoglobin, plasma 1-4 mg/dL
Leukocyte count and differential  
Leukocyte count 4,500-11,000/mm3
Segmented neutrophils 54%-62%
Bands 3%-5%
Eosinophils 1%-3%
Basophils 0%-0.75%
Lymphocytes 25%-33%
Monocytes 3%-7%
Mean corpuscular hemoglobin 25.4-34.6 pg/cell
Mean corpuscular hemoglobin concentration 31%-36% Hb/cell
Mean corpuscular volume 80-100 μm3
Partial thromboplastin time (activated) 25-40 seconds
Platelet count 150,000-400,000/mm3
Prothrombin time 11-15 seconds
Reticulocyte count 0.5%-1.5% of red cells
Thrombin time < 2 seconds deviation from control
Plasma Male: 25-43 mL/kg
Female: 28-45 mL/kg
Red cell Male: 20-36 mL/kg
Female: 19-31 mL/kg
Cerebrospinal Fluid Reference Range
Cell count 0-5/mm3
Chloride 118-132 mEq/L
Gamma globulin 3%-12% total proteins
Glucose 40-70 mg/dL
Pressure 70-180 mm H2O
Proteins, total < 40 mg/dL
Sweat Reference Range
Chloride 0-35 mmol/L
Calcium 100-300 mg/24 h
Chloride Varies with intake
Creatinine clearance Male: 97-137 mL/min
Female: 88-128 mL/min
Estriol, total (in pregnancy)  
30 wks 6-18 mg/24 h
35 wks 9-28 mg/24 h
40 wks 13-42 mg/24 h
17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 h
Female: 2.0-8.0 mg/24 h
17-Ketosteroids, total Male: 8-20 mg/24 h
Female: 6-15 mg/24 h
Osmolality 50-1400 mOsmol/kg H2O
Oxalate 8-40 μg/mL
Potassium Varies with diet
Proteins, total < 150 mg/24 h
Sodium Varies with diet
Uric acid Varies with diet
Body Mass Index (BMI) Adult: 19-25 kg/m2

You have 100% on this question.
Just skip this one for now.

(M1.MC.74) Two patients are vaccinated for poliomyelitis. Patient A receives the Sabin oral vaccine, and Patient B receives the Salk intramuscular vaccine. Six weeks after their initial vaccinations, which of the following would be the greatest difference regarding these two patients? Review Topic

QID: 106656

Patient A has a higher level of duodenal IgA antibodies




Patient B has a higher level of duodenal IgA antibodies




Patient A has a lower level of serum IgA antibodies




Patient B has a lower level of serum IgM antibodies




Patient A has a higher level of serum IgG antibodies




Select Answer to see Preferred Response

Topic COMMENTS (28)
Private Note